2-[1-(3-{6-[(1E)-(Hydroxyimino)Methyl]-5-Methyl-4-Oxo-7-Propyl-3H,4H-Pyrrolo[2,1-F][1,2,4]Triazin-2-Yl}-4-Propoxybenzenesulfonyl)Piperidin-4-Yl]Ethyl Nitrate

1 trials 1 recruiting

Filter these 1 trials by condition, phase, country and more.

1 Registered trials

1 Recruiting

0 Completed trials

2 Sponsors

1 Countries

Phase I (FiH)

Phase I (FiH): 1

Indications tested

1 total

Safety and tolerability of TOP-N53 applied on digital ulcers in patients with systemic sclerosis Recruiting

2024-511861-12-00 Phase I (FiH) 1 country Topadur Pharma AG; Topadur Pharma Deutschland GmbH

Showing 1–1 of 1 trials